This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Flagship Pioneering Innovations Vi, LLC. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Gregory David McAllister: Innovator in Gene Modifying Systems
Introduction
Gregory David McAllister is a notable inventor based in Canton, MA (US). He has made significant contributions to the field of gene editing, particularly in the development of therapies for cystic fibrosis. His innovative work has the potential to impact the lives of many individuals affected by genetic disorders.
Latest Patents
McAllister holds a patent for "CFTR-modulating compositions and methods." This patent encompasses compositions, systems, and methods designed to target, edit, modify, or manipulate a host cell's genome at specific locations within a DNA sequence. The gene modifying systems described in his patent are particularly aimed at treating cystic fibrosis in subjects with the F508del mutation.
Career Highlights
Throughout his career, McAllister has been associated with Flagship Pioneering Innovations Vi, LLC, where he has been able to apply his expertise in genetic engineering. His work has been instrumental in advancing the understanding and treatment of genetic conditions.
Collaborations
Some of his notable coworkers include Robert Charles Altshuler and Anne Helen Bothmer. Their collaborative efforts contribute to the innovative environment at Flagship Pioneering Innovations Vi, LLC.
Conclusion
Gregory David McAllister is a pioneering inventor whose work in gene modifying systems holds promise for the treatment of cystic fibrosis. His contributions to the field of genetic engineering are noteworthy and reflect his commitment to improving healthcare through innovation.